Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Caitlyn MCKEEVER |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Novel Therapeutics in Autism Spectrum Disorders / Evdokia ANAGNOSTOU
Titre : Novel Therapeutics in Autism Spectrum Disorders Type de document : Texte imprimé et/ou numérique Auteurs : Evdokia ANAGNOSTOU, Auteur ; Caitlyn MCKEEVER, Auteur ; Azadeh KUSHKI, Auteur Année de publication : 2013 Importance : p.103-109 Langues : Anglais (eng) Index. décimale : SCI-D SCI-D - Neurosciences Résumé : Although ASD (autistic spectrum disorder) has seen significant gains in the area of therapeutics over the last 2 decades, it has also been characterized by the inability to successfully treat core symptom domains. In this chapter, we discuss challenges faced in this area, including limitations related to measuring outcomes, ability to capture the heterogeneity of ASD adequately, and lack of data in the rapidly growing adult population who have ASD. We then discuss novel approaches to therapeutics research in ASD, which include translating emerging findings from genomics, neuropathology and animal models into treatment, and discuss potential novel molecular targets in this area, such as glutamate/GABA related pathways, oxytocin/vasopressin, and immune modulation. The need to combine such treatments with evolving psychoeducational interventions is highlighted as it has the potential to modify the developmental trajectories of individuals with ASD. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=189 Novel Therapeutics in Autism Spectrum Disorders [Texte imprimé et/ou numérique] / Evdokia ANAGNOSTOU, Auteur ; Caitlyn MCKEEVER, Auteur ; Azadeh KUSHKI, Auteur . - 2013 . - p.103-109.
Langues : Anglais (eng)
Index. décimale : SCI-D SCI-D - Neurosciences Résumé : Although ASD (autistic spectrum disorder) has seen significant gains in the area of therapeutics over the last 2 decades, it has also been characterized by the inability to successfully treat core symptom domains. In this chapter, we discuss challenges faced in this area, including limitations related to measuring outcomes, ability to capture the heterogeneity of ASD adequately, and lack of data in the rapidly growing adult population who have ASD. We then discuss novel approaches to therapeutics research in ASD, which include translating emerging findings from genomics, neuropathology and animal models into treatment, and discuss potential novel molecular targets in this area, such as glutamate/GABA related pathways, oxytocin/vasopressin, and immune modulation. The need to combine such treatments with evolving psychoeducational interventions is highlighted as it has the potential to modify the developmental trajectories of individuals with ASD. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=189 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire